Qol-O-04 - EORTC-QLQ-C30 and SKINDEX-29 measurement of health-related quality of life in patients with mycosis fungoides and Sézary syndrome: real-world data in Spanish patients (MICADOS study)

Autor: del Mar Onteniente Gomis, María, Matilla, Belén Navarro, Pujol Vallverdú, Ramón María, Escudero, Andrea Combalia, Paz, Irma Zapata, Barca, Eva González, Montserrat, Cristina Muniesa, Andújar, Mercedes Morillo, Ferriols, Amparo Pérez, Curto, Concepción Román, de Misa Cabrera, Ricardo Fernández, Gil, Mercedes Hospital, Niebla, Ana Marín, Rios Rull, Pablo Jesús, De la Cruz Vicente, Fátima, Izu Belloso, Rosa María, García-Sancho, Alejandro Martín, Parera Amer, María Elisabet, Mascuñano, Raúl Córdoba, Ramón Quiles, María Dolores, Carreres, Ana Saus, Del Campo García, Raquel, Machan, Salma, Ester, Pablo Viguera, Garnelo, Julia Blanco, López, Begoña Soler, Ortiz Romero, Pablo Luis

Publikováno v: In European Journal of Cancer October 2021 156 Supplement 1:S29-S30

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

EORTC-QLQ-C30 and SKINDEX-29 measurement of health-related quality of life in patients with mycosis fungoides and Sézary syndrome: real-world data in Spanish patients (MICADOS study).

Autor: Del Mar Onteniente Gomis M; Hospital Universitario 12 de Octubre, Dermatology Department, Madrid, Spain., Matilla BN; Hospital Universitario Puerta de Hierro, Hematology Department, Madrid, Spain., Pujol Vallverdú RM; Hospital del Mar, Dermatology Department, Barcelona, Spain., Escudero AC; Hospital Universitario Clínic i Provincial, Dermatology Department, Barcelona, Spain., Paz IZ; Hospital Universitario Puerta de Hierro, Oncology Radiation Department, Madrid, Spain., Barca EG; Institut Catalá D'Oncología - Hospitalet, Hematology Department, Barcelona, Spain., Montserrat CM; Hospital Universitario de Bellvitge, Dermatology Department, Barcelona, Spain., Andújar MM; Hospital Universitario Virgen del Rocío, Dermatology Department, Sevilla, Spain., Ferriols AP; Hospital General Universitario de Valencia, Dermatology Department, Valencia, Spain., Curto CR; Hospital General Universitario de Salamanca, Dermatology Department, Salamanca, Spain., de Misa Cabrera RF; Hospital Universitario Nuestra Señora de Candelaria, Dermatology Department, Santa Cruz de Tenerife (Islas Canarias), Spain., Gil MH; Hospital Universitario Puerta de Hierro, Dermatology Department, Madrid, Spain., Niebla AM; Hospital Universitario Vall d'Hebron/VHIO, Hematology Department, Barcelona, Spain., Rios Rull PJ; Hospital Universitario Nuestra Señora de Candelaria, Hematology Department, Santa Cruz de Tenerife (Islas Canarias), Spain., De la Cruz Vicente F; Hospital Universitario Virgen del Rocío, Hematology Department, Sevilla, Spain., Izu Belloso RM; Hospital de Basurto, Bilbao (Vizcaya), Spain., García-Sancho AM; Hospital General Universitario de Salamanca, Hematology Department, Salamanca, Spain., Parera Amer ME; Hospital Son Llàtzer, Dermatology Department, Palma de Mallorca (Islas Baleares), Spain., Mascuñano RC; Hospital Universitario Fundación Jiménez Díaz, Hematology Department, Madrid, Spain., Ramón Quiles MD; Hospital Clínico Universitario, Dermatology Department, Valencia, Spain., Carreres AS; Hospital Clínico Universitario, Hematology Department, Valencia, Spain., Del Campo García R; Hospital Son Llàtzer, Hematology Department, Palma de Mallorca (Islas Baleares), Spain., Machan S; Hospital Universitario Fundación Jiménez Díaz, Dermatology Department, Madrid, Spain., Ester PV; Kyowa Kirin Farmacéutica, S.L., Medical Department, Madrid, Spain., Garnelo JB; Kyowa Kirin Farmacéutica, S.L., Medical Department, Madrid, Spain., López BS; E-C-BIO, S.L. Medical Department, Madrid, Spain., Ortiz Romero PL; Hospital Universitario 12 de Octubre, Dermatology Department, Madrid, Spain.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Oct; Vol. 156 Suppl 1, pp. S29-S30.